154 related articles for article (PubMed ID: 31286610)
1. Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.
Swartz JA; Beltran SJ
Addiction; 2019 Nov; 114(11):2016-2025. PubMed ID: 31286610
[TBL] [Abstract][Full Text] [Related]
2. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
3. Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs.
Cher BAY; Morden NE; Meara E
Med Care; 2019 Mar; 57(3):208-212. PubMed ID: 30629018
[TBL] [Abstract][Full Text] [Related]
4. Association between state Medicaid expansion status and naloxone prescription dispensing.
Sohn M; Talbert JC; Delcher C; Hankosky ER; Lofwall MR; Freeman PR
Health Serv Res; 2020 Apr; 55(2):239-248. PubMed ID: 32030751
[TBL] [Abstract][Full Text] [Related]
5. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
[TBL] [Abstract][Full Text] [Related]
6. The Opioid Epidemic Blunted the Mortality Benefit of Medicaid Expansion.
Yan BW; Sloan FA; Boscardin WJ; Guo F; Dudley RA
Med Care Res Rev; 2021 Apr; 78(2):103-112. PubMed ID: 32403982
[TBL] [Abstract][Full Text] [Related]
7. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
Johnson NL; Choi S; Herrera CN
J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
[TBL] [Abstract][Full Text] [Related]
8. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
Saloner B; Levin J; Chang HY; Jones C; Alexander GC
JAMA Netw Open; 2018 Aug; 1(4):e181588. PubMed ID: 30646116
[TBL] [Abstract][Full Text] [Related]
9. Medicaid expansion and opioid overdose mortality among socioeconomically disadvantaged populations in the US: A difference in differences analysis.
Ibragimov U; Mansfield RW; Yarbrough CR; Cummings JR; Livingston MD; Haardörfer R; Beane S; Fadanelli MM; Haley DF; Cooper HLF
Drug Alcohol Depend; 2022 Apr; 233():109381. PubMed ID: 35259679
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Young Adult Dependent Coverage Expansion on Opioid Overdoses and Deaths: a Quasi-Experimental Study.
Coupet E; Werner RM; Polsky D; Karp D; Delgado MK
J Gen Intern Med; 2020 Jun; 35(6):1783-1788. PubMed ID: 31898130
[TBL] [Abstract][Full Text] [Related]
11. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
[TBL] [Abstract][Full Text] [Related]
12. Overdose deaths involving prescription opioids among Medicaid enrollees - Washington, 2004-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(42):1171-5. PubMed ID: 19875978
[TBL] [Abstract][Full Text] [Related]
13. The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder.
Mojtabai R; Mauro C; Wall MM; Barry CL; Olfson M
Psychiatr Serv; 2019 Jul; 70(7):617-620. PubMed ID: 31035894
[TBL] [Abstract][Full Text] [Related]
14. Association of Medicaid Expansion With Health Insurance Coverage Among Persons With a Disability.
Stimpson JP; Kemmick Pintor J; McKenna RM; Park S; Wilson FA
JAMA Netw Open; 2019 Jul; 2(7):e197136. PubMed ID: 31314115
[TBL] [Abstract][Full Text] [Related]
15. Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.
Hartung DM; Johnston KA; Hallvik S; Leichtling G; Geddes J; Hildebran C; Keast S; Chan B; Korthuis PT
J Gen Intern Med; 2020 Nov; 35(11):3188-3196. PubMed ID: 32935311
[TBL] [Abstract][Full Text] [Related]
16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
17. US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016.
Gaither JR; Shabanova V; Leventhal JM
JAMA Netw Open; 2018 Dec; 1(8):e186558. PubMed ID: 30646334
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients.
Garg RK; Fulton-Kehoe D; Franklin GM
Med Care; 2017 Jul; 55(7):661-668. PubMed ID: 28614178
[TBL] [Abstract][Full Text] [Related]
19. Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.
Pro G; Montgomery BEE; Zaller N
Subst Abuse Treat Prev Policy; 2021 Jun; 16(1):50. PubMed ID: 34147098
[TBL] [Abstract][Full Text] [Related]
20. The impact of expanded Medicaid eligibility on access to naloxone.
Frank RG; Fry CE
Addiction; 2019 Sep; 114(9):1567-1574. PubMed ID: 30983009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
